Original Research
Accepted on 29 Jul 2025
Perioperative Outcomes of Neoadjuvant Chemotherapy plus Camrelizumab versus Neoadjuvant Chemotherapy plus Tislelizumab for Locally Advanced Esophageal Squamous Cell Cancer: A Real-World Retrospective Study
in Cancer Immunity and Immunotherapy